Thalidomide and its analogues in the treatment of Multiple Myeloma

Multiple myeloma is an incurable malignant disorder of mature B-cells that predominantly affects the elderly. The immunomodulatory drug (IMiD) thalidomide and its newer analogs demonstrate increased antitumor activity, and have had a positive impact on the natural history of multiple myeloma. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Latif, Tahir, Chauhan, Nabeel, Khan, Rashid, Moran, Andrea, Usmani, Saad Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514107/
https://www.ncbi.nlm.nih.gov/pubmed/23210501
http://dx.doi.org/10.1186/2162-3619-1-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514107/
https://www.ncbi.nlm.nih.gov/pubmed/23210501
http://dx.doi.org/10.1186/2162-3619-1-27

Ejemplares similares